← SynDRA
EVOGLIPTIN
SynDRA canonical compound SYN0027062 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | DPP4 |
|---|
| Mechanism of action | dipeptidyl peptidase inhibitor |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- DPP4 inhibitor
- dipeptidyl peptidase inhibitor
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- suganon
- DA-1229
- Evogliptine
- Evogliptina
- DA1229
- DPP-IV inhibitor (tablet, type II diabetes), Dong-A
- evogliptina
- evogliptine
- evogliptinum
- RefChem:139681
- DTXCID1076036
- A10BH07
- Evogliptin [INN]
- UNII-09118300L7
- Evogliptin (INN)
- EVOGLIPTIN [WHO-DD]
- SCHEMBL343846
- orb1688089
- SCHEMBL30866226
- LCDDAGSJHKEABN-MLGOLLRUSA-N
- GLXC-10991
- BDBM50344779
- DA-53077
- HY-117985
- CS-0068793
- NS00072931
- C92448
- D11023
- T61949
- 8VU
- اووگلیپتین
- RefChem:1064198
- CS-0113505
- DA-53078
- EX-A12323
- HY-117985B
- Evogliptin (tartrate)
- MS-30083
Look up EVOGLIPTIN in the interactive SynDRA portal →